Mohsen MO - Search Results

1

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.

Vogt AS, Jörg L, Martina B, Krenger PS, Chang X, Zeltins A, Vogel M, Mohsen MO, Bachmann MF. Vogt AS, et al. Among authors: mohsen mo. Front Immunol. 2022 Jun 16;13:864718. doi: 10.3389/fimmu.2022.864718. eCollection 2022. Front Immunol. 2022. PMID: 35784292 Free PMC article.

2

Harnessing Nanoparticles for Immunomodulation and Vaccines.

Gomes AC, Mohsen M, Bachmann MF. Gomes AC, et al. Vaccines (Basel). 2017 Feb 14;5(1):6. doi: 10.3390/vaccines5010006. Vaccines (Basel). 2017. PMID: 28216554 Free PMC article. Review.

3

Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination.

Mohsen MO, Gomes AC, Cabral-Miranda G, Krueger CC, Leoratti FM, Stein JV, Bachmann MF. Mohsen MO, et al. J Control Release. 2017 Apr 10;251:92-100. doi: 10.1016/j.jconrel.2017.02.031. Epub 2017 Feb 28. J Control Release. 2017. PMID: 28257987

4

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA, Kramer MF, Bachmann MF. Cabral-Miranda G, et al. Among authors: mohsen mo. Vaccines (Basel). 2017 May 2;5(2):10. doi: 10.3390/vaccines5020010. Vaccines (Basel). 2017. PMID: 28468322 Free PMC article.

5

Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.

Zha L, He L, Xie W, Cheng J, Li T, Mohsen MO, Lei F, Storni F, Bachmann M, Chen H, Zhang Y. Zha L, et al. Among authors: mohsen mo. PLoS One. 2017 May 31;12(5):e0177964. doi: 10.1371/journal.pone.0177964. eCollection 2017. PLoS One. 2017. PMID: 28562667 Free PMC article.

6

Major findings and recent advances in virus-like particle (VLP)-based vaccines.

Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF. Mohsen MO, et al. Semin Immunol. 2017 Dec;34:123-132. doi: 10.1016/j.smim.2017.08.014. Epub 2017 Sep 5. Semin Immunol. 2017. PMID: 28887001 Review.

7

Microcrystalline Tyrosine (MCT^®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.

Cabral-Miranda G, Heath MD, Gomes AC, Mohsen MO, Montoya-Diaz E, Salman AM, Atcheson E, Skinner MA, Kramer MF, Reyes-Sandoval A, Bachmann MF. Cabral-Miranda G, et al. Among authors: mohsen mo. Vaccines (Basel). 2017 Sep 27;5(4):32. doi: 10.3390/vaccines5040032. Vaccines (Basel). 2017. PMID: 28953265 Free PMC article.

8

An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb.

Zha L, Leoratti FMS, He L, Mohsen MO, Cragg M, Storni F, Vogel M, Bachmann MF. Zha L, et al. Among authors: mohsen mo. J Allergy Clin Immunol. 2018 Nov;142(5):1529-1536.e6. doi: 10.1016/j.jaci.2017.09.054. Epub 2018 Jan 31. J Allergy Clin Immunol. 2018. PMID: 29391255

9

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.

Mohsen MO, Gomes AC, Vogel M, Bachmann MF. Mohsen MO, et al. Vaccines (Basel). 2018 Jul 2;6(3):37. doi: 10.3390/vaccines6030037. Vaccines (Basel). 2018. PMID: 30004398 Free PMC article. Review.

10

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases.

Klimek L, Kündig T, Kramer MF, Guethoff S, Jensen-Jarolim E, Schmidt-Weber CB, Palomares O, Mohsen MO, Jakob T, Bachmann M. Klimek L, et al. Among authors: mohsen mo. Allergo J Int. 2018;27(8):245-255. doi: 10.1007/s40629-018-0074-y. Epub 2018 Jul 9. Allergo J Int. 2018. PMID: 30546996 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page